ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,343Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 336

$632K Total Retail Price of All Prescriptions

Rank: 109 out of 336

452 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 9,229 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 487 358 1 3
LISINOPRIL 414 303 2 6
AMLODIPINE BESYLATE 399 332 3 1
FUROSEMIDE 391 369 4 4
SIMVASTATIN 381 309 5 5
LEVOTHYROXINE SODIUM 276 229 6 7
HYDROCODONE-ACETAMINOPHEN 236 165 S3 7 2
WARFARIN SODIUM 212 206 8 17
ZOLPIDEM TARTRATE 168 106 9 18
ATORVASTATIN CALCIUM 164 116 10 14
DONEPEZIL HCL 163 147 11 27
TRAMADOL HCL 158 119 12 20
BENAZEPRIL HCL 156 156 13 59
NEXIUM 142 90 14 24
GABAPENTIN 135 101 15 11
DIOVAN 129 129 16 31
CARVEDILOL 127 107 17 13
AMLODIPINE BESYLATE-BENAZEPRIL 124 107 18 47
SERTRALINE HCL 116 107 19 33
HYDROCHLOROTHIAZIDE 115 71 20 12
LOSARTAN POTASSIUM 113 94 21 22
CLOPIDOGREL 113 103 21 28
METOPROLOL SUCCINATE 106 85 23 15
PRAVASTATIN SODIUM 97 97 24 10
MELOXICAM 95 74 25 19
METFORMIN HCL 95 77 25 8
CITALOPRAM HBR 92 66 27 21
ESCITALOPRAM OXALATE 83 55 28 69
AZITHROMYCIN 81 64 29 58
SYNTHROID 77 76 30 43
CRESTOR 75 74 31 25
POTASSIUM CHLORIDE 75 75 31 9
GLIMEPIRIDE 75 64 31 29
SPIRIVA 73 67 34 88
METOPROLOL TARTRATE 72 61 35 16
PAROXETINE HCL 71 63 36 64
CYMBALTA 71 43 36 52
LOVASTATIN 70 51 38 34
MECLIZINE HCL 70 55 38 96
BUSPIRONE HCL 70 44 38 113
LANTUS 68 42 41 56
CYCLOBENZAPRINE HCL 67 45 R 42 65
LIPITOR 67 50 42 62
LYRICA 66 55 44 70
CIPROFLOXACIN HCL 65 52 45 55
SPIRONOLACTONE 65 55 45 42
NAMENDA 64 61 47 39
PLAVIX 63 59 48 37
SINGULAIR 62 62 49 85
ISOSORBIDE MONONITRATE ER 61 50 50 44
EXFORGE 59 56 51 121
BYSTOLIC 57 51 52 79
LEVOFLOXACIN 54 45 53 93
SYMBICORT 54 54 53 155
PANTOPRAZOLE SODIUM 54 42 53 40
METFORMIN HCL ER 54 35 53 61
TRIAMTERENE-HCTZ 53 53 57 35
ALENDRONATE SODIUM 53 51 57 54
INSULIN SYRINGE 53 33 57 102
JANUMET 52 43 60 134
LUNESTA 52 36 60 255
RANITIDINE HCL 51 46 62 36
DIGOXIN 51 50 62 50
GLYBURIDE-METFORMIN HCL 50 50 R 64 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.